165
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Clinical Oncology

Diagnosis and treatment of breast cancer in Denmark during the COVID-19 pandemic: a nationwide population-based study

ORCID Icon, , , ORCID Icon, , & show all
Pages 1749-1756 | Received 07 Jul 2023, Accepted 11 Sep 2023, Published online: 26 Sep 2023

References

  • Skovlund CW, Friis S, Dehlendorff C, et al. Drop in cancer diagnosis during the COVID-19 pandemic in Denmark: assessment of impact during 2020. Acta Oncol. 2021;60(1):20–23. doi: 10.1080/0284186X.2020.1858235.
  • Olesen TB, Jensen H, Møller H, et al. Nation-wide mammography screening participation in Denmark during the COVID-19 pandemic: an observational study. Under review (pre-print available at medRxiv). 2022.
  • Dinmohamed AG, Cellamare M, Visser O, et al. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in The Netherlands. J Hematol Oncol. 2020;13(1):147. doi: 10.1186/s13045-020-00984-1.
  • Eijkelboom AH, de Munck L, Lobbes MBI, et al. Impact of the suspension and restart of the dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic. Prev Med. 2021;151:106602. doi: 10.1016/j.ypmed.2021.106602.
  • Eijkelboom AH, de Munck L, Vrancken Peeters M, et al. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in The Netherlands: a population-based study. J Hematol Oncol. 2021;14(1):64. doi: 10.1186/s13045-021-01073-7.
  • Dalton SO, Düring M, Ross L, et al. The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983–1999. Br J Cancer. 2006;95(5):653–659. doi: 10.1038/sj.bjc.6603294.
  • Dalton SO, Olsen MH, Johansen C, et al. Socioeconomic inequality in cancer survival - changes over time. A population-based study, Denmark, 1987-2013. Acta Oncol. 2019;58(5):737–744. doi: 10.1080/0284186X.2019.1566772.
  • Statistics Denmark. [cited 2021 Jan 17]. Available from: https://www.dst.dk/en#.
  • Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians–a national Danish project. Health Policy. 2012;105(1):65–70. doi: 10.1016/j.healthpol.2011.11.001.
  • Schmidt M, Pedersen L, Sørensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi: 10.1007/s10654-014-9930-3.
  • Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591. doi: 10.2147/CLEP.S179083.
  • Statens Serum Institut. Overvågningdata for covid-19 i Danmark og Europa [cited 2021 Jan 17]. Available from: https://covid19.ssi.dk/overvagningsdata.
  • Pottegård A, Kristensen KB, Reilev M, et al. Existing data sources in clinical epidemiology: the Danish COVID-19 cohort. Clin Epidemiol. 2020;12:875–881. doi: 10.2147/CLEP.S257519.
  • Sundhedsstyrelsen. Vaccinationskalender 2021 Available from: https://www.sst.dk/da/udgivelser/2021/vaccinationskalender.
  • Statens Serum Institut. Vaccination mod covid-19 [cited 2021 Jan 17]. Available from: https://covid19.ssi.dk/vaccination.
  • Christiansen P, Ejlertsen B, Jensen MB, et al. Danish breast cancer cooperative group. Clin Epidemiol. 2016;8:445–449. doi: 10.2147/CLEP.S99457.
  • Schmidt M, Schmidt SA, Sandegaard JL, et al. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi: 10.2147/CLEP.S91125.
  • Bjerregaard B, Larsen OB. The danish pathology register. Scand J Public Health. 2011;39(7 Suppl):72–74. doi: 10.1177/1403494810393563.
  • DBCG kvalitetsdatabase for brystkræft, national årsrapport 2022. The Danish Clinical Quality Program – National Clinical Registries 2023.
  • Ng JS, Hamilton DG. Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: a rapid review and meta-analysis. J Med Screen. 2022;29(4):209–218. doi: 10.1177/09691413221101807.
  • Greene G, Griffiths R, Han J, et al. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system. Br J Cancer. 2022;127(3):558–568. doi: 10.1038/s41416-022-01830-6.
  • Caswell-Jin JL, Shafaee MN, Xiao L, et al. Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population. Breast Cancer Res Treat. 2022;194(2):475–482. doi: 10.1007/s10549-022-06634-z.
  • de Bock E, Herman ES, Bastian OW, et al. Systematic review and meta-analysis determining the effect of implemented COVID-19 guidelines on surgical oncology volumes and clinical outcomes. Surg Oncol. 2022;45:101859. doi: 10.1016/j.suronc.2022.101859.
  • Habbous S, Tai X, Beca JM, et al. Comparison of use of neoadjuvant systemic treatment for breast cancer and short-term outcomes before vs during the COVID-19 era in Ontario, Canada. JAMA Netw Open. 2022;5(8):e2225118. doi: 10.1001/jamanetworkopen.2022.25118.
  • Kripalani S, Kulshreshta S, Saracco B, et al. The effect of COVID-19 on breast cancer care and treatment in North America: a scoping review. Am J Surg. 2022;224(5):1222–1228. doi: 10.1016/j.amjsurg.2022.07.015.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.